Wei Duan
- Pharmacology top 0.1%
- Pharmacogenetics and Drug Metabolism 13
- Cancer Research top 1%
- Molecular Biology top 0.5%
- RNA Interference and Gene Delivery 46
- Advanced biosensing and bioanalysis techniques 45
- Extracellular vesicles in disease 14
- Cancer therapeutics and mechanisms 11
- Biomaterials top 0.5%
- Nanoparticle-Based Drug Delivery 25
-
- Cancer Cells and Metastasis 22
-
- Immune Cell Function and Interaction 12
Wei Duan
339 papers receiving 14.3k citations
Hit Papers
Peers
Comparison fields: 5 of 184
- Pharmacology 1.2k
- Cancer Research 1.4k
- Molecular Biology 6.4k
- Complementary and alternative medicine 766
- Biomaterials 1.2k
Countries citing papers authored by Wei Duan
This map shows the geographic impact of Wei Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Duan more than expected).
Fields of papers citing papers by Wei Duan
This network shows the impact of papers produced by Wei Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Duan. The network helps show where Wei Duan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Wei Duan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 16 | |
| 5 | 2024 | 26 | |
| 6 | 2024 | 1 | |
| 7 | 2024 | 12 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 5 | |
| 10 | 2021 | 0 | |
| 11 | 2020 | 75 | |
| 12 | 2020 | 54 | |
| 13 | 2020 | 249 | |
| 14 | 2018 | 1 | |
| 15 | 2017 | 29 | |
| 16 | 2017 | 44 | |
| 17 | 2016 | 8 | |
| 18 | 2013 | 272 | |
| 19 | 2011 | 64 | |
| 20 | 2004 | 129 |
About Wei Duan
Wei Duan is a scholar working on Biomaterials, Molecular Biology and Oncology, having authored 354 papers that have together received 14.6k indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (46 papers), Advanced biosensing and bioanalysis techniques (45 papers), Nanoparticle-Based Drug Delivery (25 papers), Cancer Cells and Metastasis (22 papers), Extracellular vesicles in disease (14 papers), Pharmacogenetics and Drug Metabolism (13 papers), Immune Cell Function and Interaction (12 papers) and Cancer therapeutics and mechanisms (11 papers). The work is most often cited by research in Pharmacology (1.2k citations), Cancer Research (1.4k citations) and Molecular Biology (6.4k citations). Wei Duan has collaborated with scholars based in China, Australia and United States. Frequent co-authors include Sarah Shigdar, Shu‐Feng Zhou, Eli Chan, Michael Croft, Yong Li, Xin‐Gui Li, Yuliang Yang, Sui Yung Chan, Dongxi Xiang and W.S. Fred Wong. Their work appears in journals such as Current Drug Metabolism, Cancer Letters, International Journal of Pharmaceutics, Pharmaceutical Research and Theranostics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.